The p53 tumor antigen [1,2,3,4,5] is a protein found in increased amounts in a
wide variety of transformed cells. It is also detectable in many proliferating
nontransformed cells, but it is undetectable or present at low levels in
resting cells. It is frequently mutated or inactivated in many types of
cancer. p53 seems to act as a tumor suppressor in some, but probably not all,
tumor types. p53 is probably involved in cell cycle regulation, and may be a
trans-activator that acts to negatively regulate cellular division by
controlling a set of genes required for this process.
p53 is a phosphoprotein of about 390 amino acids which can be subdivided into
four domains: a highly charged acidic region of about 75 to 80 residues, a
hydrophobic proline-rich domain (position 80 to 150), a central region (from
150 to about 300), and a highly basic C-terminal region. The sequence of p53
is well conserved in vertebrate species; attempts to identify p53 in other
eukaryotic philum has so far been unsuccessful.
The p53 protein belongs to a family  that also includes:
p51 (p63 or Ket), a transcriptional activator.
p73, a transcriptional activator that participates in the apoptotic
response to DNA damage.
As a signature pattern for this family we selected a conserved stretch of 13
residues located in the central region of the protein. This region, known as
domain IV in , is involved (along with an adjacent region) in the binding
of the large T antigen of SV40. In man this region is the focus of a variety
of point mutations in cancerous tumors.
December 2001 / Pattern and text revised.
PROSITE method (with tools and information) covered by this documentation:
PROSITE is copyright. It is produced by the SIB Swiss Institute
Bioinformatics. There are no restrictions on its use by non-profit
institutions as long as its content is in no way modified. Usage by and
for commercial entities requires a license agreement. For information
about the licensing scheme send an email to
or see: prosite_license.html.